Day: February 1, 2021

J Clin Aesthet Dermatol. 2021;14(2):12–13. Dear Editor: In their recent article, Lowery et al1 argue that iPLEDGE should remove abstinence as a contraceptive method, requiring individuals with reproductive potential to

J Clin Aesthet Dermatol. 2021;14(2):12–13. Dear Editor: iPLEDGE, the risk evaluation and mitigation strategy program for isotretinoin, has been criticized for being unnecessarily complex, antiquated, and ineffective. It mandates that